Meridian Bioscience (Meridian Bioscience) EV-to-EBIT : 26.02 (As of May. 12, 2024)

Meridian Bioscience EV-to-EBIT Chart

Meridian Bioscience Annual Data
	Trend	Sep13	Sep14	Sep15	Sep16	Sep17	Sep18	Sep19	Sep20	Sep21	Sep22
EV-to-EBIT		Get a 7-Day Free Trial					19.50	12.50	12.16	9.21	23.94

Meridian Bioscience Quarterly Data
	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22
EV-to-EBIT	Get a 7-Day Free Trial															9.21	11.21	13.42	21.69	23.94

Competitive Comparison of Meridian Bioscience's EV-to-EBIT

For the Diagnostics & Research subindustry, Meridian Bioscience's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Meridian Bioscience's EV-to-EBIT Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Meridian Bioscience's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Meridian Bioscience's EV-to-EBIT falls into.

Meridian Bioscience EV-to-EBIT Calculation

Meridian Bioscience's EV-to-EBIT for today is calculated as:

Meridian Bioscience's current Enterprise Value is $1,444.5 Mil.
Meridian Bioscience's EBIT for the trailing twelve months (TTM) ended in Sep. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $55.5 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Meridian Bioscience  (NAS:VIVO) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Meridian Bioscience's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2022 is calculated as:

Meridian Bioscience's Enterprise Value for the quarter that ended in Sep. 2022 was $1,328.8 Mil.
Meridian Bioscience's EBIT for the trailing twelve months (TTM) ended in Sep. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $55.5 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Meridian Bioscience EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Meridian Bioscience's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Meridian Bioscience (Meridian Bioscience) Business Description